Black Friday saleUp to 70% OFF
EEE

NOVA EYE MEDICAL LIMITED

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast Seasonals

EYE chart


Full chart

EYE upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪34.36 M‬ AUD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.045 AUD
Net income (FY)
‪−8.79 M‬ AUD
Revenue (FY)
‪23.32 M‬ AUD
Shares float
‪220.41 M‬
Beta (1Y)
1.37

About NOVA EYE MEDICAL LIMITED


Sector
Health Technology
Industry
Medical Specialties
CEO
Thomas Spurling
Website
nova-eye.com
Headquarters
Kent Town
Founded
1970
ISIN
AU0000094252
FIGI
BBG000BT1XB7
Nova Eye Medical Ltd. engages in developing suite of novel ophthalmic treatment technologies. It operates through the following segments: Faster Growing (iTrack), Emerging (2RT), and Core Ophthalmic Mark (Lasers and Ultrasounds). The iTrack segment offers catheter device that dilates the ocular structures compromised by glaucoma. The 2RT segment includes patent-protected with significant lead on competition and a per-use recurring fee business model. The Lasers and Ultrasounds segment represents testimony to the strength of the Ellex brand and was driven by growth in sales of the high-margin Ellex Tango and Ellex Tango Reflex glaucoma lasers. The company was founded by Giuseppe Canala and Victor Previn in 1985 and is headquartered in Kent Town, Australia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

EYE news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of EYE is 0.155 AUD — it has increased by 3.45% in the past 24 hours. Watch NOVA EYE MEDICAL LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange NOVA EYE MEDICAL LIMITED stocks are traded under the ticker EYE.
EYE stock has fallen by −9.09% compared to the previous week, the month change is a −16.67% fall, over the last year NOVA EYE MEDICAL LIMITED has showed a 9.78% increase.
We've gathered analysts' opinions on NOVA EYE MEDICAL LIMITED future price: according to them, EYE price has a max estimate of 0.70 AUD and a min estimate of 0.48 AUD. Watch EYE chart and read a more detailed NOVA EYE MEDICAL LIMITED stock forecast: see what analysts think of NOVA EYE MEDICAL LIMITED and suggest that you do with its stocks.
EYE reached its all-time high on Sep 22, 1995 with the price of 5.405 AUD, and its all-time low was 0.080 AUD and was reached on Dec 4, 2008. View more price dynamics on EYE chart.
See other stocks reaching their highest and lowest prices.
EYE stock is 6.80% volatile and has beta coefficient of 1.37. Track NOVA EYE MEDICAL LIMITED stock price on the chart and check out the list of the most volatile stocks — is NOVA EYE MEDICAL LIMITED there?
Yes, you can track NOVA EYE MEDICAL LIMITED financials in yearly and quarterly reports right on TradingView.
NOVA EYE MEDICAL LIMITED is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
EYE net income for the last half-year is ‪−3.17 M‬ AUD, while the previous report showed ‪−5.63 M‬ AUD of net income which accounts for 43.73% change. Track more NOVA EYE MEDICAL LIMITED financial stats to get the full picture.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOVA EYE MEDICAL LIMITED EBITDA is ‪−5.98 M‬ AUD, and current EBITDA margin is −25.63%. See more stats in NOVA EYE MEDICAL LIMITED financial statements.
Like other stocks, EYE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVA EYE MEDICAL LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NOVA EYE MEDICAL LIMITED technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NOVA EYE MEDICAL LIMITED stock shows the strong sell signal. See more of NOVA EYE MEDICAL LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.